QSC Peptides · Lipolytic peptide
HGH Fragment 176-191 is a stabilized analog of amino acids 176–191 of human growth hormone. It retains the lipolytic (fat-mobilizing) activity of the C-terminal HGH region without the growth-promoting effects of full-length somatropin. Used in adipose tissue and metabolic research. QSC Peptides offers 5mg and 10mg vials.
HGH Fragment 176-191 is a stabilized synthetic analog of amino acids 176–191 of the human growth hormone molecule — specifically the C-terminal alpha-helical region. This 16-amino-acid fragment retains the lipolytic activity associated with full-length HGH while lacking the N-terminal region required for GHR binding and growth-promoting effects.
The fragment activates hormone-sensitive lipase (HSL) in adipocytes via a mechanism that does not require GHR binding, driving triglyceride hydrolysis and free fatty acid (FFA) release — the core lipolytic effect attributed to the C-terminus of HGH.
Full-length HGH (somatropin) has two main functional domains:
HGH Fragment 176-191 isolates only the lipolytic domain, enabling research into fat metabolism without the confounding anabolic and growth-promoting effects of full-length somatropin from QSC Peptides.
Research-grade · ≥99% purity · COA · Free USA USPS/FedEx · US domestic warehouse
QSC Peptides · Lipolytic peptide
QSC Peptides
QSC Peptides
QSC Peptides